Pain doesn’t follow a protocol.
Compounded formulations let physicians prescribe for the specific patient in front of them, with the strength, dosage form, and route that fit when a commercial product doesn't.
Too many patients feel stuck between two options: live with the pain, or take more of what isn't working.
Chronic pain rarely has a single cause, so it rarely has a single answer. Several compounds physicians are turning to aren't commercially available at the strengths, dosage forms, or routes used in practice.
Start low, adjust as your patient responds, and build them into the plan you're already managing.
Chronic pain rarely has a single cause, so it rarely has a single answer. Several compounds physicians are turning to aren't commercially available at the strengths, dosage forms, or routes used in practice.
We compound them to your prescription so you can start low, adjust as your patient responds, and build them into the plan you're already managing.
-
LDN is prescribed off-label for chronic pain conditions, including fibromyalgia and complex regional pain syndrome (CRPS). Published studies have reported improvements in pain and related symptoms in some patients. Typical LDN doses are a small fraction of the 50 mg commercial tablet, so it has to be compounded.
-
ULDN is used at microgram-level doses, far below LDN. It has been studied mainly alongside opioid therapy. For patients managing pain while on opioids, it gives physicians another variable to work with. At doses this small, precise compounding matters.
-
GLP-1s are best known for metabolic health. Research is now looking at their role in inflammation and in pain driven by excess weight, including a large trial in knee osteoarthritis. For patients whose pain and metabolic health are linked, they can be part of the same conversation.
For physicians who treat the whole picture: pain, physical dependence, and recovery.
Built with physicians. Developed for what's next.
Product development is at the heart of what we do. Our pharmacists work directly with physicians to respond to real-world needs, developing new formulations as the field evolves.
As part of the GenoGenRX family, we're connected from raw-material sourcing through formulation and quality assurance, so a new idea can move from conversation to prescription.
Compounding is most powerful when the pharmacy thinks about the patient the way the physician does.
-
Twenty years of specialty compounding across complex, patient-specific formulations.
-
Pharmacists available for clinical consultation, not just order fulfillment.
-
±5% potency tolerance, USP 795/797/800, independent third-party testing.
-
Certificate of Compliance with every batch, sourcing and formulation documentation on request.
GenoGenRx compounds ultra-low-dose and low-dose naltrexone, along with other formulations for recovery and metabolic support, at the dose levels physicians need for pain, dependence, and recovery care.
We customize the formulation to the patient, not the other way around. That's not just pain relief. That's a life handed back.
